TANIS, STEVEN P.,LARSEN, SCOTT D.,PARKER, TIMOTHY,ARTMAN, GERALD D., III
申请号：
CA2918376
公开号：
CA2918376A1
申请日:
2014.07.21
申请国别(地区):
CA
年份:
2015
代理人:
摘要：
The present invention relates to hydroxamate compounds and pharmaceutical compositions that are useful for treating and/or preventing metabolic inflammation mediated diseases such as diabetes, obesity, hypertension, dyslipidemia, a neurodegenerative disorder (e.g., Alzheimer's disease, Parkinson's disease, or Huntington's disease), or any combination thereof. Moreover, the present invention also provides methods of treatment for these diseases or disorders.
